JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on September 12, 2003
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
278/37/34743    most recent
C300249200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu-Baer, F.
Right arrow Articles by Baer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu-Baer, F.
Right arrow Articles by Baer, R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print July 30, 2003
J. Biol. Chem, 10.1074/jbc.C300249200
Submitted on June 6, 2003
Revised on July 28, 2003
Accepted on July 30, 2003

The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin

Foon Wu-Baer, Karen Lagrazon, Wei Yuan, and Richard Baer

Institute for Cancer Genetics, Columbia University, New York, NY 10032

Corresponding Author: rb670{at}columbia.edu

The BRCA1 tumor suppressor forms a heterodimer with the BARD1 protein, and the resulting complex functions as an E3 ubiquitin ligase that catalyzes the synthesis of polyubiquitin chains. In theory, polyubiquitination can occur by isopeptide bond formation at any of the seven lysine residues of ubiquitin. The isopeptide linkage of a polyubiquitin chain is a particularly important determinant of its cellular function, such that K48-linked chains commonly target proteins for proteasomal degradation while K63 chains serve non-proteolytic roles in various signaling pathways. To determine the isopeptide linkage formed by BRCA1/BARD1-dependent polyubiquitination, we purified a full-length heterodimeric complex and compared its linkage specificity to that of E6-AP, an E3 ligase known to induce proteolysis of its cellular substrates. Using a comprehensive mutation analysis, we found that E6-AP catalyzes the synthesis of K48-linked polyubiquitin chains. In contrast, however, the BRCA1/BARD1 heterodimer directs polymerization of ubiquitin primarily through an unconventional linkage involving lysine residue K6. Although heterologous substrates of BRCA1/BARD1 are not known, BRCA1 autoubiquitination occurs principally by conjugation with K6-linked polymers. The ability of BRCA1/BARD1 to form K6-linked polyubiquitin chains suggests that it may impart unique cellular properties to its natural enzymatic substrates.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
X. H. Yang and L. Zou
Launching a ubiquitination cascade at DNA breaks
PNAS, December 26, 2007; 104(52): 20645 - 20646.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. Bish and M. P. Myers
Werner Helicase-interacting Protein 1 Binds Polyubiquitin via Its Zinc Finger Domain
J. Biol. Chem., August 10, 2007; 282(32): 23184 - 23193.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. T. Kim, K. P. Kim, F. Lledias, A. F. Kisselev, K. M. Scaglione, D. Skowyra, S. P. Gygi, and A. L. Goldberg
Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages
J. Biol. Chem., June 15, 2007; 282(24): 17375 - 17386.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
B. Sobhian, G. Shao, D. R. Lilli, A. C. Culhane, L. A. Moreau, B. Xia, D. M. Livingston, and R. A. Greenberg
RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites
Science, May 25, 2007; 316(5828): 1198 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. A. Horwitz, E. B. Affar, G. F. Heine, Y. Shi, and J. D. Parvin
A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase
PNAS, April 17, 2007; 104(16): 6614 - 6619.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Lu, A. Amleh, J. Sun, X. Jin, S. D. McCullough, R. Baer, D. Ren, R. Li, and Y. Hu
Ubiquitination and Proteasome-Mediated Degradation of BRCA1 and BARD1 during Steroidogenesis in Human Ovarian Granulosa Cells
Mol. Endocrinol., March 1, 2007; 21(3): 651 - 663.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Wu, H. Nishikawa, R. Hayami, K. Sato, A. Honda, S. Aratani, T. Nakajima, M. Fukuda, and T. Ohta
BRCA1 Ubiquitinates RPB8 in Response to DNA Damage
Cancer Res., February 1, 2007; 67(3): 951 - 958.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kee, W. Munoz, N. Lyon, and J. M. Huibregtse
The Deubiquitinating Enzyme Ubp2 Modulates Rsp5-dependent Lys63-linked Polyubiquitin Conjugates in Saccharomyces cerevisiae
J. Biol. Chem., December 1, 2006; 281(48): 36724 - 36731.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity
Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
X. Yu, S. Fu, M. Lai, R. Baer, and J. Chen
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.
Genes & Dev., July 1, 2006; 20(13): 1721 - 1726.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Mani and E. P. Gelmann
The Ubiquitin-Proteasome Pathway and Its Role in Cancer
J. Clin. Oncol., July 20, 2005; 23(21): 4776 - 4789.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. M. Starita, A. A. Horwitz, M.-C. Keogh, C. Ishioka, J. D. Parvin, and N. Chiba
BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II
J. Biol. Chem., July 1, 2005; 280(26): 24498 - 24505.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer
Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells
J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
F. E. Kleiman, F. Wu-Baer, D. Fonseca, S. Kaneko, R. Baer, and J. L. Manley
BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II
Genes & Dev., May 15, 2005; 19(10): 1227 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Pastushok, T. F. Moraes, M. J. Ellison, and W. Xiao
A Single Mms2 "Key" Residue Insertion into a Ubc13 Pocket Determines the Interface Specificity of a Human Lys63 Ubiquitin Conjugation Complex
J. Biol. Chem., May 6, 2005; 280(18): 17891 - 17900.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Hayami, K. Sato, W. Wu, T. Nishikawa, J. Hiroi, R. Ohtani-Kaneko, M. Fukuda, and T. Ohta
Down-regulation of BRCA1-BARD1 Ubiquitin Ligase by CDK2
Cancer Res., January 1, 2005; 65(1): 6 - 10.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
T. Frazier, D. Shakes, U. Hota, and L. Boyd
Caenorhabditis elegans UBC-2 functions with the anaphase-promoting complex but also has other activities
J. Cell Sci., October 15, 2004; 117(22): 5427 - 5435.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. M. Starita, Y. Machida, S. Sankaran, J. E. Elias, K. Griffin, B. P. Schlegel, S. P. Gygi, and J. D. Parvin
BRCA1-Dependent Ubiquitination of {gamma}-Tubulin Regulates Centrosome Number
Mol. Cell. Biol., October 1, 2004; 24(19): 8457 - 8466.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. R. Schoenfeld, S. Apgar, G. Dolios, R. Wang, and S. A. Aaronson
BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage
Mol. Cell. Biol., September 1, 2004; 24(17): 7444 - 7455.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. D. Choudhury, H. Xu, and R. Baer
Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression
J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Sato, R. Hayami, W. Wu, T. Nishikawa, H. Nishikawa, Y. Okuda, H. Ogata, M. Fukuda, and T. Ohta
Nucleophosmin/B23 Is a Candidate Substrate for the BRCA1-BARD1 Ubiquitin Ligase
J. Biol. Chem., July 23, 2004; 279(30): 30919 - 30922.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. R. Morris and E. Solomon
BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair
Hum. Mol. Genet., April 15, 2004; 13(8): 807 - 817.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Nishikawa, S. Ooka, K. Sato, K. Arima, J. Okamoto, R. E. Klevit, M. Fukuda, and T. Ohta
Mass Spectrometric and Mutational Analyses Reveal Lys-6-linked Polyubiquitin Chains Catalyzed by BRCA1-BARD1 Ubiquitin Ligase
J. Biol. Chem., February 6, 2004; 279(6): 3916 - 3924.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.